Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FGF21, a liver hormone that inhibits alcohol intake in mice, increases in human circulation after acute alcohol ingestion and sustained binge drinking at Oktoberfest
Susanna Søberg, Emilie S. Andersen, Niels B. Dalsgaard, et al.
Molecular Metabolism (2018) Vol. 11, pp. 96-103
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases
Ana L. Cardoso, Adelaide Fernandes, Juan Antonio Aguilar‐Pimentel, et al.
Ageing Research Reviews (2018) Vol. 47, pp. 214-277
Open Access | Times Cited: 396
A Dozen Years of Discovery: Insights into the Physiology and Pharmacology of FGF21
Steven A. Kliewer, David J. Mangelsdorf
Cell Metabolism (2019) Vol. 29, Iss. 2, pp. 246-253
Open Access | Times Cited: 216
Metabolic Messengers: FGF21
Kyle H. Flippo, Matthew J. Potthoff
Nature Metabolism (2021) Vol. 3, Iss. 3, pp. 309-317
Open Access | Times Cited: 200
Therapeutic Landscape for NAFLD in 2020
Brent A. Neuschwander‐Tetri
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1984-1998.e3
Closed Access | Times Cited: 168
Brown Adipose Crosstalk in Tissue Plasticity and Human Metabolism
Camilla Schéele, Christian Wolfrum
Endocrine Reviews (2019) Vol. 41, Iss. 1, pp. 53-65
Open Access | Times Cited: 152
New developments in the biology of fibroblast growth factors
David M. Ornitz, Nobuyuki Itoh
WIREs Mechanisms of Disease (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 96
Brown Adipose Tissue—A Translational Perspective
André C. Carpentier, Denis P. Blondin, François Haman, et al.
Endocrine Reviews (2022) Vol. 44, Iss. 2, pp. 143-192
Open Access | Times Cited: 96
FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond
Stephen A. Harrison, Timothy P. Rolph, Madeline Knott, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 562-576
Closed Access | Times Cited: 32
Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases
Christoffer Clemmensen, Brian Finan, Timo D. Müller, et al.
Nature Reviews Endocrinology (2018) Vol. 15, Iss. 2, pp. 90-104
Closed Access | Times Cited: 104
AKR-001, an Fc-FGF21 Analog, Showed Sustained Pharmacodynamic Effects on Insulin Sensitivity and Lipid Metabolism in Type 2 Diabetes Patients
Allegra Kaufman, Lubna Abuqayyas, William S. Denney, et al.
Cell Reports Medicine (2020) Vol. 1, Iss. 4, pp. 100057-100057
Open Access | Times Cited: 102
Recent Efforts to Dissect the Genetic Basis of Alcohol Use and Abuse
Sandra Sanchez‐Roige, Abraham A. Palmer, Toni‐Kim Clarke
Biological Psychiatry (2019) Vol. 87, Iss. 7, pp. 609-618
Open Access | Times Cited: 92
FGF21 and the Physiological Regulation of Macronutrient Preference
Cristal M. Hill, Emily Qualls‐Creekmore, Hans‐Rudolf Berthoud, et al.
Endocrinology (2020) Vol. 161, Iss. 3
Open Access | Times Cited: 78
FGF21 suppresses alcohol consumption through an amygdalo-striatal circuit
Kyle H. Flippo, Samuel A.J. Trammell, Matthew P. Gillum, et al.
Cell Metabolism (2022) Vol. 34, Iss. 2, pp. 317-328.e6
Open Access | Times Cited: 58
The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model
Redin A. Spann, Christopher D. Morrison, Laura J. den Hartigh
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 44
The role of FGF21 and its analogs on liver associated diseases
Kimia Falamarzi, Mahdi Malekpour, Mobin Fallah Tafti, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 38
FGF21 counteracts alcohol intoxication by activating the noradrenergic nervous system
Mihwa Choi, Marc Schneeberger, Wei Fan, et al.
Cell Metabolism (2023) Vol. 35, Iss. 3, pp. 429-437.e5
Open Access | Times Cited: 27
Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho
Alexandra S. Aaldijk, Cristy R.C. Verzijl, Johan W. Jonker, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 26
FGF21 in obesity and cancer: New insights
Weiqin Lu, Xiaokun Li, Yongde Luo
Cancer Letters (2020) Vol. 499, pp. 5-13
Open Access | Times Cited: 63
Circulating FGF21 Levels in Human Health and Metabolic Disease
Michaela Keuper, Hans‐Ulrich Häring, Harald Staiger
Experimental and Clinical Endocrinology & Diabetes (2019) Vol. 128, Iss. 11, pp. 752-770
Closed Access | Times Cited: 59
LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest Hypertriglyceridemia
Daniel J. Rader, Eleftheria Maratos–Flier, A. Nguyen, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 1, pp. e57-e70
Open Access | Times Cited: 48
The Saga of Endocrine FGFs
Phuc Phan, Bibhuti Ballav Saikia, Shivakumar Sonnaila, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2418-2418
Open Access | Times Cited: 45
Homeostatic sensing of dietary protein restriction: A case for FGF21
Cristal M. Hill, Hans‐Rudolf Berthoud, Heike Münzberg, et al.
Frontiers in Neuroendocrinology (2018) Vol. 51, pp. 125-131
Open Access | Times Cited: 57
Fibroblast growth factor 21: An emerging pleiotropic regulator of lipid metabolism and the metabolic network
Shuo Li, Tiande Zou, Jun Chen, et al.
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 101064-101064
Open Access | Times Cited: 15
Binge drinking episode causes acute, specific alterations in systemic and hepatic inflammation‐related markers
Evelina Stankevič, Mads Israelsen, Helene Bæk Juel, et al.
Liver International (2023) Vol. 43, Iss. 12, pp. 2680-2691
Open Access | Times Cited: 15
Hepatic interoception in health and disease
Hans‐Rudolf Berthoud, Heike Münzberg, Christopher D. Morrison, et al.
Autonomic Neuroscience (2024) Vol. 253, pp. 103174-103174
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top